The Healthcare Company Setup Guide
to Saudi Arabia

A foreign-owned Saudi healthcare entity needs three licences before a single patient is seen. The MISA foreign-investment licence sits at the top — issued by the Ministry of Investment, this is what makes 100% foreign ownership of a hospital, clinic, day-surgery centre or pharmacy chain possible. Healthcare was added to the 100%-foreign-ownership list in 2021; before that, joint venture with a Saudi partner was the only route.

The MOH facility licence sits beneath it — issued by the Ministry of Health for the specific facility (the building, the bed count, the activities and the head physician). MOH licences are facility-specific; opening a second clinic means a second MOH file, even under the same Commercial Registration.

The CCHI insurer-network registration is the third layer — issued by the Council of Cooperative Health Insurance to bring the facility into the insured-patient network. Without it, the facility is cash-pay only, which excludes most expat patients (who are insured by employer mandate) and most middle-class Saudi patients (who carry private insurance alongside the public system).

The Saudi Central Board for Accreditation of Healthcare Institutions (CBAHI) is the national quality regulator. Hospital accreditation is mandatory within 18 months of MOH licensing. For clinics and day-surgery centres, accreditation is rapidly becoming a de-facto requirement for CCHI insurer-network inclusion and Health Holding Company contract eligibility.

CBAHI is structured around the National Hospital Standards (over 1,200 measurable elements across 30 chapters) and dedicated standards for ambulatory care, primary care, dental, dialysis, home health, medical labs, blood banks and emergency medical services. Accreditation surveys are unannounced after the initial baseline visit.

Plan accreditation as a 12–18 month operational programme starting before the facility opens — quality systems, infection control, patient safety, governance committees, credentialing files and clinical documentation all need to be live and evidenced from day one of patient activity. Retro-fitting CBAHI compliance into a running facility is roughly twice as expensive as building it in.

The Saudi Council for Health Specialties (SCFHS) regulates individual practice for every physician, nurse, dentist, pharmacist, physiotherapist, lab technician and allied-health professional in the Kingdom. The pipeline for a foreign clinician runs through three stages: Dataflow primary-source verification of credentials (4–8 weeks), SCFHS classification against Saudi specialty equivalents (2–4 weeks), and the SCFHS prometric examination for most specialties (variable scheduling, 2–6 week wait).

Senior consultants in shortage specialties (oncology, cardiac surgery, neurosurgery, transplant medicine) can route through the SCFHS Distinguished Practitioner pathway, which waives the prometric requirement against academic and clinical evidence. This is the route most international hospital operators use for their senior leadership.

Saudization sub-quotas now run profession by profession — for example, pharmacists at 35%, nurses at 30% (with strong push toward 50% by 2030), and allied-health technicians at 25%. The Saudization framework is set out in Volume 14 — Saudization & Nitaqat.

The National Unified Procurement Company (NUPCO) is the consolidated procurement arm for almost all public-sector healthcare spending — Ministry of Health, the Health Holding Companies, military medical services, Aramco Health Services, university hospitals and the National Guard Health Affairs.

Vendor onboarding requires SFDA product registration (Saudi Food and Drug Authority — variable timelines, 6–18 months for new molecules and devices), GS1 KSA product coding, Saudi Made certification for any product manufactured in-Kingdom (which carries procurement preference points and price-tier protection), and RHQ qualification if you intend to bid for contracts above SAR 1M as a foreign supplier.

Demand-side reform: the MOH has spun off most of the operational hospital network into Health Holding Companies (Riyadh First Health Cluster, Eastern HHC, Madinah HHC, and others), which now run patient flow, contract clinical services and buy locally. The HHCs are corporate buyers, not government departments — procurement cycles are faster and value-based contracting is now real.

The Health Sector Transformation Programme (HSTP) under Vision 2030 is moving Saudi healthcare from a hospital-centric, public-payer model to a Model of Care built around primary care, integrated chronic-disease management, virtual consultations and value-based contracts.

For a foreign operator, this re-prices the opportunity set: primary-care networks (chains of 20–50 GP clinics) are now the highest-growth segment; specialty day-surgery (orthopaedics, ophthalmology, dermatology, IVF) is consolidating into branded operator groups; digital health (Sehhaty, Tawakkalna, telehealth platforms) is a near-mandate distribution channel; chronic-disease management (diabetes, cardiovascular, oncology) is moving toward bundled-payment contracts with the HHCs.

Capital intensity is real: a single hospital build runs SAR 200M–800M before equipping; a polyclinic chain SAR 5M–15M per node. Most foreign operators enter through a management-contract route (operating an existing PIF or HHC asset) before committing greenfield capital. Tamra structures both routes — see Company Setup in Saudi Arabia for the entity choices.